English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 8 December 2023, 14:30 HKT/SGT
Share:
GNMI: Update on Discloseable Transaction Deemed Disposal of Equity Interest in Chesir Luzhai

HONG KONG, Dec 8, 2023 - (ACN Newswire) - On December 6, 2023, Global New Material International Holdings Limited (the "Company", or "GNMI", Stock Code: 06616.HK) disclosed the latest progress of the Capital Increase Agreement in Chesir Luzhai.

The Board is pleased to announce that, as at the date hereof, all of the conditions precedent to the Capital Increase Agreement have been fulfilled, and the total consideration for the Capital Increase in the amount of RMB1 billion in cash has been received by Chesir Luzhai from the Investor.

According to the announcement of GNMI dated 20 November 2023 (the "Announcement"), Chesir Luzhai, an indirect non-wholly owned subsidiary of the Company, and the Investor entered into the Capital Increase Agreement, pursuant to which the Investor has conditionally agreed to inject RMB1 billion in cash into Chesir Luzhai. Upon Completion, Chesir Luzhai will remain as the core subsidiary of the Company and its financial results will continue to be consolidated in the Group's accounts.

GNMI has made significant progress towards its goals and maintained a steady momentum of business development. Simultaneously, the Company has been actively seeking international acquisition opportunities with strong foundations and advanced technology to further enhance its core competitiveness. In August 2023, GNMI successfully completed the acquisition of CQV, a famous pearlescent pigment manufacturer in Korea and a renowned brand in the global pearlescent pigment industry, which marks a milestone in the Group's international expansion plans.

The Company has also announced its intention to seize opportunities and expand its business presence in the international pearlescent pigments industry. It will continue to follow the strategy of "Endogenous Development and Outward Expansion" to accelerate the Group's various strategic plans. The completion of the Capital Increase Agreement will provide the Company with additional working capital for future developments.

About Global New Material International Holdings Limited

Global New Material International specializes in the manufacturing and sale of pearlescent pigment products and synthetic mica. Leveraging the unique materials, the Company offers an expansive range of over 1000 distinct product variations catering to diverse industrial, exterior, and cosmetic applications. The company is known as the largest pearlescent pigment producer in China and the third largest globally.

About the Investor

The Investor is wholly-owned by Tonglu Technology and Innovation Industry Development and Investment Company Limited, which in turn is wholly-owned by Tonglu County State-owned Asset Management Committee, being the ultimate beneficial owner of the Investor.



Topic: Press release summary Sectors: Chemicals, Spec.Chem
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Maxon One Winter Release Brings Holiday Cheer from Concept to Render  
Dec 5, 2024 00:00 HKT/SGT
Autobrains and JOYNEXT Revolutionize Smart Camera Solution Powered by Autobrains' Affordable Safety ADAS Software  
Dec 4, 2024 22:20 HKT/SGT
CITIC Telecom CPC's Internal and External Cybersecurity Excellence Honored with 3 Industry Awards  
Dec 4, 2024 22:10 HKT/SGT
Naoris Protocol announces World's First Post-Quantum DePIN for Cybersecurity & Digital Trust ahead of Testnet  
Dec 4, 2024 21:26 HKT/SGT
25th Hong Kong Forum concludes successfully  
Dec 4, 2024 21:00 HKT/SGT
DENSO Signs Memorandum of Understanding with Canatu of Finland for Practical Application of Carbon Nanotube Technology  
Wednesday, December 4, 2024 4:51:00 PM
Sweetness Affecting Both the Young and Old: Prevent Diabetes with LAC This World Diabetes Day  
Dec 4, 2024 14:30 HKT/SGT
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy  
Dec 4, 2024 11:08 HKT/SGT
DeAgentAI and OKX Wallet Join Forces: $50K DA Token Airdrop for Web3 Enthusiasts  
Dec 4, 2024 09:45 HKT/SGT
Japan Maritime Defense Force Selects SeaGuardians From GA-ASI  
Dec 4, 2024 08:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575